tobramycin
ticarcillin
therapy
exacerbations
pulmonary
disease
patients
cystic
fibrosis
patients
cystic
fibrosis
acute
infectious
exacerbations
pulmonary
disease
produced
pseudomonas
aeruginosa
treated
combination
tobramycin
ticarcillin
p
aeruginosa
recovered
patients
inhibited
lower
concentrations
drugs
gentamicin
carbenicillin
thirteen
courses
treatment
administered
patients
mean
days
favorable
response
seen
completed
courses
treatment
improvement
associated
decreases
white
blood
cell
count
temperature
sedimentation
rate
adverse
reactions
uncommon
although
p
aeruginosa
eradicated
sputum
clinical
results
suggest
combination
tobramycin
ticarcillin
may
particularly
useful
treatment
acute
exacerbations
pulmonary
disease
patients
cystic
fibrosis
p
aeruginosa
isolated
